ABOUT U-73122

Notwithstanding different setbacks, quite a few MDM2 inhibitors have now progressed into late-phase scientific enhancement. New approaches have also been designed to reinforce the efficacy of MDM2 inhibitors and also to mitigate their on-goal toxicity. During this evaluation, we summarize the progress and challenges in the development of a MDM2 qua